Location History:
- Kensington, MA (US) (2012)
- Cambridge, MA (US) (2015)
- Canton, MA (US) (1991 - 2021)
- Quincy, MA (US) (2015 - 2022)
Company Filing History:
16 out of 16 
5 out of 34 
4 out of 4 
Years Active: 1991-2022
Title: **Gary E. Borodic: Innovator in Ocular Pharmacology**
Introduction
Gary E. Borodic, based in Canton, MA, is a distinguished inventor renowned for his innovative contributions to ocular pharmacology. With a remarkable portfolio of 31 patents, Borodic has significantly advanced the treatment options available for ocular surface diseases and age-related macular degeneration. His groundbreaking work reflects his commitment to enhancing patient care through innovative pharmaceutical compositions.
Latest Patents
Among Borodic's latest patents is a topical ocular preparation of botulinum toxin designed specifically for use in ocular surface disease. This novel composition allows for superior penetration into the ocular surface, including the conjunctiva and cornea, thereby minimizing the need for frequent allergy drops traditionally used to treat ocular surface inflammation. The method of application described in this patent eliminates the necessity of needle puncture, enhancing the overall safety and comfort for patients.
Another notable patent focuses on a method of treating macular degeneration utilizing botulinum toxin-based pharmaceuticals. This invention outlines formulations for the prevention and/or treatment of visual loss connected to age-related macular degeneration. These formulations incorporate botulinum neurotoxin and, in some cases, anti-VEGF agents, and they can be applied to regions outside of the eye. Remarkably, the formulations may reach the intraocular region through axoplasmic transport, mitigating the risks associated with direct injections, such as retinal detachment and hemorrhage.
Career Highlights
Borodic has made significant strides in the pharmaceutical industry, highlighting his role at Botulinum Toxin Research Associates, Inc., where his research and innovations have led to substantial advancements in the field. His dedication to improving ocular health is evident in his extensive patent portfolio, showcasing his ability to innovate within a highly specialized domain.
Collaborations
Throughout his career, Borodic has collaborated with notable individuals such as Martin Andrew Acquadro and Eric Arthur Johnson. These partnerships have undoubtedly enriched his research endeavors and have facilitated the development of cutting-edge therapeutic solutions for ocular conditions.
Conclusion
Gary E. Borodic's contributions to ocular pharmacology underscore the vital role of innovation in advancing medical treatments. His patents not only reflect technical ingenuity but also a profound understanding of patient needs in ocular health. As the field continues to evolve, Borodic’s work serves as an inspiring example for future inventors and researchers committed to enhancing the quality of life through innovative medical solutions.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.